Abstract |
|
Authors | Vitaliana De Sanctis, Marco Alfò, Alice Di Rocco, Michela Ansuinelli, Eleonora Russo, Mattia F Osti, Maurizio Valeriani, Giuseppe Minniti, Lavinia Grapulin, Daniela Musio, Stefano Bracci, Alessandra Spagnoli, Maria Luisa Moleti, Vincenzo Tombolini, Maurizio Martelli |
Journal | Hematological oncology
(Hematol Oncol)
Vol. 35
Issue 4
Pg. 554-560
(Dec 2017)
ISSN: 1099-1069 [Electronic] England |
PMID | 28078727
(Publication Type: Journal Article)
|
Copyright | Copyright © 2017 John Wiley & Sons, Ltd. |
Chemical References |
- Bleomycin
- Vincristine
- Doxorubicin
- Cyclophosphamide
- Leucovorin
- Prednisone
- Methotrexate
|
Topics |
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects, therapeutic use)
- Bleomycin
(adverse effects, therapeutic use)
- Cancer Survivors
- Combined Modality Therapy
(adverse effects, methods)
- Cyclophosphamide
(adverse effects, therapeutic use)
- Doxorubicin
(adverse effects, therapeutic use)
- Female
- Humans
- Incidence
- Kaplan-Meier Estimate
- Leucovorin
(adverse effects, therapeutic use)
- Lymphoma, B-Cell
(diagnosis, mortality, therapy)
- Male
- Mediastinal Neoplasms
(diagnosis, mortality, therapy)
- Methotrexate
(adverse effects, therapeutic use)
- Middle Aged
- Neoplasms, Second Primary
(diagnosis, epidemiology, etiology)
- Prednisone
(adverse effects, therapeutic use)
- Radiotherapy
(adverse effects, methods)
- Risk
- Treatment Outcome
- Vincristine
(adverse effects, therapeutic use)
- Young Adult
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|